$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Is nivolumab a PD-1 inhibitor?
2025-10-19 11:44:20
Check Details
Safety, tolerability and efficacy of nivolumab in advanced non-small cell lung cancer
2025-10-19 11:44:20
Check Details
How much does a box of lung cancer targeted drug ceritinib cost? Where can I buy it?
2025-10-19 11:44:20
Check Details
Safety and efficacy of nivolumab monotherapy in the treatment of advanced or metastatic squamous non-small cell lung cancer
2025-10-19 11:44:20
Check Details
Effect data of nivolumab in treatment of previously treated advanced non-small cell lung cancer
2025-10-19 11:44:20
Check Details
Lung cancer immunotherapy welcomes new drug-nivolumab
2025-10-19 11:44:20
Check Details
Entrectinib brings new option for ROS1-positive lung cancer
2025-10-19 11:44:20
Check Details
Safety and effectiveness of ramucirumab combined with erlotinib in the treatment of EGFR mutated lung cancer
2025-10-19 11:44:20
Check Details
Will ramucirumab be included in the national medical insurance directory in 2021?
2025-10-19 11:44:20
Check Details
Data on the efficacy of entrectinib in the treatment of ROS1-positive non-small cell lung cancer
2025-10-19 11:44:20
Check Details
How much does a cycle of ramucirumab cost for lung cancer?
2025-10-19 11:44:20
Check Details
The difference between ramucirumab and bevacizumab_Canghule
2025-10-19 11:44:20
Check Details
1
2
...
3885
3886
3887
3888
3889
3890
3891
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
2
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
3
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
4
Cemiplimab (Libtayo) Drug Information
5
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
6
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
7
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
8
A Revolutionary Targeted Therapy for Hematological Malignancies
9
A New Option for Advanced Renal Cell Carcinoma Treatment
10
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
11
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
12
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide